البحث عن طبيب

Michael S. Torbenson, M.D.

  1. Pathologist
طلب موعد

المنشورات

  1. Anderson CM, Welle CL, Ludwig DR, Anderson MA, Khot R, Itani M, Zulfiqar M, Torbenson MS, Venkatesh SK. Autoimmune Disorders of the Liver and Biliary Tract. Radiographics. 2025 Apr; 45 (4):e240126
    View PubMed
  2. Requena D, Medico JA, Soto-Ugaldi LF, Shirani M, Saltsman JA 3rd, Torbenson MS, Coffino P, Simon SM. Liver cancer multiomics reveals diverse protein kinase A disruptions convergently produce fibrolamellar hepatocellular carcinoma. Nat Commun. 2024 Dec 30; 15 (1):10887
    View PubMed
  3. Clouston AD, Gouw ASH, Tiniakos D, Bedossa P, Brunt EM, Callea F, Dienes HP, Goodman ZD, Hubscher SG, Kakar S, Kleiner DE, Lackner C, Park YN, Roberts EA, Schirmacher P, Terracciano L, Torbenson M, Wanless IR, Zen Y, Burt AD. Severe acute liver disease in adults: Contemporary role of histopathology. Histopathology. 2024 Oct; 85 (4):549-561 Epub 2024 May 21
    View PubMed
  4. Pulaski H, Mehta SS, Manigat LC, Kaufman S, Hou H, Nalbantoglu I, Zhang X, Curl E, Taliano R, Kim TH, Torbenson M, Glickman JN, Resnick MB, Patel N, Taylor CE, Bedossa P, Montalto MC, Beck AH, Wack KE. Validation of a whole slide image management system for metabolic-associated steatohepatitis for clinical trials. J Pathol Clin Res. 2024 Sep; 10 (5):e12395
    View PubMed
  5. Venkatesh SK, Harper KC, Borhani AA, Furlan A, Thompson SM, Chen EZM, Idilman IS, Miller FH, Hoodeshenas S, Navin PJ, Gu CN, Welle CL, Torbenson MS. Hepatic Sinusoidal Disorders. Radiographics. 2024 Sep; 44 (9):e240006
    View PubMed
  6. Shirani M, Levin S, Shebl B, Requena D, Finkelstein TM, Johnson DS, Ng D, Lalazar G, Heissel S, Hojrup P, Molina H, de Jong YP, Rice CM, Singhi AD, Torbenson MS, Coffino P, Lyons B, Simon SM. Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1. Cancer Res. 2024 Aug 15; 84 (16):2626-2644
    View PubMed
  7. Yang Y, Wang J, Wan J, Cheng Q, Cheng Z, Zhou X, Wang O, Shi K, Wang L, Wang B, Zhu X, Chen J, Feng D, Liu Y, Jahan-Mihan Y, Haddock AN, Edenfield BH, Peng G, Hohenstein JD, McCabe CE, O'Brien DR, Wang C, Ilyas SI, Jiang L, Torbenson MS, Wang H, Nakhleh RE, Shi X, Wang Y, Bi Y, Gores GJ, Patel T, Ji B. PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice. J Hepatol. 2024 Jul; 81 (1):120-134 Epub 2024 Feb 28
    View PubMed
  8. Soon GST, Callea F, Burt AD, Cook S, Terracciano L, Ercan C, Dienes HP, Goodman ZD, Roberts EA, Clouston AD, Gouw ASH, Kleiner DE, Park YN, Chung T, Schirmacher P, Tiniakos D, Dimopoulou K, Weber A, Endhardt K, Torbenson M. Steatohepatitic hepatocellular Carcinoma:A new approach to classifying morphological subtypes of hepatocellular carcinoma. Hum Pathol. 2024 Jul; 149:55-65 Epub 2024 June 12
    View PubMed
  9. Yasir S, Chen ZE, Hartley C, Zhang L, Torbenson M. Morphological findings in different subtypes of hepatic amyloid. Hum Pathol. 2024 Apr; 146:35-42 Epub 2024 Mar 07
    View PubMed
  10. Maheshwari S, Gu CN, Caserta MP, Kezer CA, Shah VH, Torbenson MS, Menias CO, Fidler JL, Venkatesh SK. Imaging of Alcohol-Associated Liver Disease. AJR Am J Roentgenol. 2024 Jan; 222 (1):e2329917 Epub 2023 Sept 20
    View PubMed
  11. Jorgenson LC, Torbenson MS, Halfdanarson TR, Kankeu Fonkoua LA, Tran NH, Roberts LR, Smoot RL, Goenka AH, Thompson SM. Immunohistochemical basis for FAP as a candidate theranostic target across a broad range of cholangiocarcinoma subtypes. Front Nucl Med. 2024; 4:1480471 Epub 2024 Nov 27
    View PubMed
  12. Soon GST, Yasir S, Jain D, Kakar S, Wu TT, Yeh MM, Torbenson MS, Chen ZE. CRP Versus SAA for Identification of Inflammatory Hepatic Adenomas. Appl Immunohistochem Mol Morphol. 2023 Oct 1; 31 (9):590-595 Epub 2023 Sept 13
    View PubMed
  13. Leiting JL, Hernandez MC, Bergquist JR, Yonkus JA, Abdelrahman AM, Torbenson MS, Tran NH, Halfdanarson TR, Graham RP, Smoot RL, Truty MJ. Therapeutic Efficacy of Temsirolimus in a Patient-derived Model of Metastatic Fibrolamellar Hepatocellular Carcinoma. In Vivo. 2023 Sep-Oct; 37 (5):1940-1950
    View PubMed
  14. Soon GST, Chen ZE, Wu TT, Torbenson MS, Yasir S. Hepatic Angiosarcomas With Sinusoidal Growth Patterns. Am J Surg Pathol. 2023 Sep 1; 47 (9):1045-1051 Epub 2023 June 26
    View PubMed
  15. Wang H, Lu J, Stevens T, Roberts A, Mandel J, Avula R, Ma B, Wu Y, Wang J, Land CV, Finkel T, Vockley JE, Airik M, Airik R, Muzumdar R, Gong Z, Torbenson MS, Prochownik EV. Premature aging and reduced cancer incidence associated with near-complete body-wide Myc inactivation. Cell Rep. 2023 Aug 29; 42 (8):112830 Epub 2023 July 22
    View PubMed
  16. Gonzalez IA, Torbenson M, Sharifai N, Byrnes K, Chatterjee D, Kakar S, Yeh MM, Wu TT, Zhang X, Jain D. Clinicopathologic characterization of hepatocellular adenomas in men: a multicenter experience. Hum Pathol. 2023 Aug; 138:24-33 Epub 2023 May 26
    View PubMed
  17. Soon GST, Yasir S, Wu TT, Welle C, Venkatesh SK, Torbenson MS, Chen ZE. Unique Morphologic Findings in the Liver After Stereotactic Radiation for Cholangiocarcinoma. Am J Surg Pathol. 2023 Jul 1; 47 (7):792-800 Epub 2023 May 19
    View PubMed
  18. Levin SN, Tomasini MD, Knox J, Shirani M, Shebl B, Requena D, Clark J, Heissel S, Alwaseem H, Surjan R, Lahasky R, Molina H, Torbenson MS, Lyons B, Migler RD, Coffino P, Simon SM. Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinoma. Sci Adv. 2023 Jun 23; 9 (25):eadg7038 Epub 2023 June 21
    View PubMed
  19. Soon GST, Torbenson M. The Liver and Glycogen: In Sickness and in Health. Int J Mol Sci. 2023 Mar 24; 24 (7)
    View PubMed
  20. Torbenson M, Venkatesh SK, Halfdanarson TR, Navin PJ, Kamath P, Erickson LA. Primary neuroendocrine tumors and primary neuroendocrine carcinomas of the liver: a proposal for a multidiscipline definition. Hum Pathol. 2023 Feb; 132:77-88 Epub 2022 July 06
    View PubMed
  21. Welle CL, Navin PJ, Olson MC, Hoodeshenas S, Torbenson MS, Venkatesh SK. MR elastography in primary sclerosing cholangitis: a pictorial review. Abdom Radiol (NY). 2023 Jan; 48 (1):63-78 Epub 2022 May 14
    View PubMed
  22. Yasir S, Thompson S, Chen ZE, Knudson R, Knutson D, Kloft-Nelson S, Graham RP, Jain D, Simon SM, Wu TT, Torbenson M. Alternative lengthening of telomeres in primary hepatic neoplasms. Hum Pathol. 2023 Jan; 131:79-86 Epub 2022 Nov 09
    View PubMed
  23. Berkovitz A, Migler RD, Qureshi A, Rosemore C, Torbenson MS, Vaughan R, Marcotte E, Simon SM. Clinical and demographic predictors of survival for fibrolamellar carcinoma patients-A patient community, registry-based study. Hepatol Commun. 2022 Dec; 6 (12):3539-3549 Epub 2022 Oct 17
    View PubMed
  24. Navin PJ, Olson MC, Mendiratta-Lala M, Hallemeier CL, Torbenson MS, Venkatesh SK. Imaging Features in the Liver after Stereotactic Body Radiation Therapy. Radiographics. 2022 Nov-Dec; 42 (7):2131-2148 Epub 2022 Oct 14
    View PubMed
  25. Narayan NJC, Requena D, Lalazar G, Ramos-Espiritu L, Ng D, Levin S, Shebl B, Wang R, Hammond WJ, Saltsman JA 3rd, Gehart H, Torbenson MS, Clevers H, LaQuaglia MP, Simon SM. Human liver organoids for disease modeling of fibrolamellar carcinoma. Stem Cell Reports. 2022 Aug 9; 17 (8):1874-1888 Epub 2022 July 07
    View PubMed
  26. Yalon M, Tahboub Amawi AD, Kelm ZS, Wells ML, Teo LLS, Heiken JP, Sheedy SP, Torbenson MS, Fidler JL, Venkatesh SK. Eosinophilic Disorders of the Gastrointestinal Tract and Associated Abdominal Viscera: Imaging Findings and Diagnosis. Radiographics. 2022 Jul-Aug; 42 (4):1081-1102 Epub 2022 June 24
    View PubMed
  27. Yasir S, Chen ZE, Jain D, Kakar S, Wu TT, Yeh MM, Torbenson MS. Hepatic Adenomas in Patients 60 and Older Are Enriched for HNF1A Inactivation and Malignant Transformation. Am J Surg Pathol. 2022 Jun 1; 46 (6):786-792 Epub 2022 Apr 06
    View PubMed
  28. Kilari S, Wang Y, Singh A, Graham RP, Iyer V, Thompson SM, Torbenson MS, Mukhopadhyay D, Misra S. Neuropilin-1 deficiency in vascular smooth muscle cells is associated with hereditary hemorrhagic telangiectasia arteriovenous malformations. JCI Insight. 2022 May 9; 7 (9) Epub 2022 May 09
    View PubMed
  29. Thompson SM, Suman G, Torbenson MS, Chen ZE, Jondal DE, Patra A, Ehman EC, Andrews JC, Fleming CJ, Welch BT, Kurup AN, Roberts LR, Watt KD, Truty MJ, Cleary SP, Smoot RL, Heimbach JK, Tran NH, Mahipal A, Yin J, Zemla T, Wang C, Fogarty Z, Jacobson M, Kemp BJ, Venkatesh SK, Johnson GB, Woodrum DA, Goenka AH. PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and (68) Ga-PSMA-11 PET Using Cyclotron-Produced (68) Ga. Hepatol Commun. 2022 May; 6 (5):1172-1185 Epub 2021 Nov 15
    View PubMed
  30. Joseph NM, Blank A, Shain AH, Gill RM, Umetsu SE, Shafizadeh N, Torbenson MS, Kakar S. Hepatocellular neoplasms with loss of liver fatty acid binding protein: Clinicopathologic features and molecular profiling. Hum Pathol. 2022 Apr; 122:60-71 Epub 2022 Jan 31
    View PubMed
  31. Venkatesh SK, Torbenson MS. Liver fibrosis quantification. Abdom Radiol (NY). 2022 Mar; 47 (3):1032-1052 Epub 2022 Jan 12
    View PubMed
  32. Torbenson MS, Erickson LA. Hemochromatosis. Mayo Clin Proc. 2022 Feb; 97 (2):423-424
    View PubMed
  33. Arnold CA, Torbenson MS. The Rodger C. Haggitt Gastrointestinal Pathology Society at the 2020 United States and Canadian Academy of Pathology: A Mini-symposium. Am J Surg Pathol 2022 Jan 1; 46 (1):1-2
    View PubMed
  34. Wang H, Lu J, Alencastro F, Roberts A, Fiedor J, Carroll P, Eisenman RN, Ranganathan S, Torbenson M, Duncan AW, Prochownik EV. Coordinated Cross-Talk Between the Myc and Mlx Networks in Liver Regeneration and Neoplasia. Cell Mol Gastroenterol Hepatol. 2022; 13 (6):1785-1804 Epub 2022 Mar 05
    View PubMed
  35. Torbenson M, McCabe CE, O'Brien DR, Yin J, Bainter T, Tran NH, Yasir S, Chen ZE, Dhanasekaran R, Ahn KS, Roberts LR, Wang C. Morphological heterogeneity in beta-catenin-mutated hepatocellular carcinomas: implications for tumor molecular classification. Hum Pathol. 2022 Jan; 119:15-27 Epub 2021 Sept 27
    View PubMed
  36. Pacheco MC, Torbenson MS, Wu TT, Kakar S, Jain D, Yeh MM. Pediatric Hepatocellular Adenomas: The Influence of Age and Syndrome on Subtype. Am J Surg Pathol. 2021 Dec 1; 45 (12):1641-1647
    View PubMed
  37. Lalazar G, Requena D, Ramos-Espiritu L, Ng D, Bhola PD, de Jong YP, Wang R, Narayan NJC, Shebl B, Levin S, Michailidis E, Kabbani M, Vercauteren KOA, Hurley AM, Farber BA, Hammond WJ, Saltsman JA 3rd, Weinberg EM, Glickman JF, Lyons BA, Ellison J, Schadde E, Hertl M, Leiting JL, Truty MJ, Smoot RL, Tierney F, Kato T, Wendel HG, LaQuaglia MP, Rice CM, Letai A, Coffino P, Torbenson MS, Ortiz MV, Simon SM. Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening. Cancer Discov. 2021 Oct; 11 (10):2544-2563 Epub 2021 June 14
    View PubMed
  38. Luo X, Campbell NA, He L, O'Brien DR, Singer MS, Lemjabbar-Alaoui H, Ahn KS, Smoot R, Torbenson MS, Rosen SD, Roberts LR. Sulfatase 2 (SULF2) Monoclonal Antibody 5D5 Suppresses Human Cholangiocarcinoma Xenograft Growth Through Regulation of a SULF2-Platelet-Derived Growth Factor Receptor Beta-Yes-Associated Protein Signaling Axis. Hepatology. 2021 Sep; 74 (3):1411-1428 Epub 2021 May 24
    View PubMed
  39. Rowan DJ, Yasir S, Chen ZE, Mounajjed T, Erdogan Damgard S, Cummins L, Zhang L, Whitcomb E, Falck V, Simon SM, Singhi AD, Torbenson MS. Morphologic and Molecular Findings in Myxoid Hepatic Adenomas. Am J Surg Pathol. 2021 Aug 1; 45 (8):1098-1107
    View PubMed
  40. Kanamori KS, Tarrago MG, Jones A, Cheek EH, Warner GM, Jenkins SM, Povero D, Graham RP, Mounajjed T, Chedid MF, Sabat BD, Torbenson MS, Heimbach JK, Chini EN, Moreira RK. Surface color spectrophotometry in a murine model of steatosis: an accurate technique with potential applicability in liver procurement. Lab Invest. 2021 Aug; 101 (8):1098-1109 Epub 2021 Apr 15
    View PubMed
  41. Kanamori KS, Tarrago MG, Jones A, Cheek EH, Warner GM, Jenkins SM, Povero D, Graham RP, Mounajjed T, Chedid MF, Sabat BD, Torbenson MS, Heimbach JK, Chini EN, Moreira RK. Surface color spectrophotometry in a murine model of steatosis: an accurate technique with potential applicability in liver procurement. Lab Invest. 2021 Aug; 101 (8):1098-1109 Epub 2023 Jan 04
    View PubMed
  42. Torbenson MS. Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns, and subtypes. Hum Pathol. 2021 Jun; 112:86-101 Epub 2020 Dec 30
    View PubMed
  43. Jones A, Kroneman TN, Blahnik AJ, Graham RP, Mounajjed T, Torbenson MS, Moreira RK. Ki-67 "hot spot" digital analysis is useful in the distinction of hepatic adenomas and well-differentiated hepatocellular carcinomas. Virchows Arch. 2021 Feb; 478 (2):201-207 Epub 2020 June 25
    View PubMed
  44. Torbenson M, Desmet V, Denk H, Callea F, Burt AD, Hubscher SG, Terracciano L, Dienes HP, Goodman ZD, Bedossa P, Wanless IR, Roberts EA, Brunt EM, Clouston AD, Gouw ASH, Kleiner D, Schirmacher P, Tiniakos D. Fifty years of impact on liver pathology: a history of the Gnomes. Virchows Arch. 2021 Feb; 478 (2):191-200 Epub 2020 June 30
    View PubMed
  45. Yasir S, Rech KL, Chen ZE, Torbenson MS. Amyloid-like Fibronectin Deposits in the Liver: A Novel Morphologic Finding. Am J Surg Pathol. 2021 Feb 1; 45 (2):205-208
    View PubMed
  46. Cheng L, Jain D, Kakar S, Torbenson MS, Wu TT, Yeh MM. Hepatocellular neoplasms arising in genetic metabolic disorders: steatosis is common in both the tumor and background liver. Hum Pathol. 2021 Feb; 108:93-99 Epub 2020 Nov 24
    View PubMed
  47. Torbenson MS, Yeh MM. Steatohepatitic hepatocellular carcinoma Hepatoma Research. 2021; 7:38
  48. Yasir S, Chen ZE, Said S, Wu TT, Torbenson M. Biopsies of hepatocellular carcinoma with no reticulin loss: an important diagnostic pitfall. Hum Pathol. 2021 Jan; 107:20-28 Epub 2020 Oct 08
    View PubMed
  49. Navin PJ, Gidener T, Allen AM, Yin M, Takahashi N, Torbenson MS, Kamath PS, Ehman RL, Venkatesh SK. The Role of Magnetic Resonance Elastography in the Diagnosis of Noncirrhotic Portal Hypertension. Clin Gastroenterol Hepatol. 2020 Dec; 18 (13):3051-3053.e2 Epub 2019 Oct 17
    View PubMed
  50. Lee HE, Torbenson MS, Wu TT, Chandan VS. Aberrant keratin expression is common in primary hepatic malignant vascular tumors: A potential diagnostic pitfall. Ann Diagn Pathol. 2020 Dec; 49:151589. Epub 2020 Aug 15.
    View PubMed
  51. Said S, Kurtin PJ, Nasr SH, Graham RP, Dasari S, Vrana JA, Yasir S, Torbenson MS, Zhang L, Mounajjed T, Chen Z, Lee , Wu T. Carboxypeptidase A1 and regenerating islet-derived 1a as new markers for pancreatic acinar cell cardinoma Human Pathology. 2020; 103:120-126. Epub 2020 Jul 21.
  52. Said S, Kurtin PJ, Nasr SH, Graham RP, Dasari S, Vrana JA, Yasir S, Torbenson MS, Zhang L, Mounajjed T, Eric Chen ZM, Lee HE, Wu TT. Carboxypeptidase A1 and regenerating islet-derived 1alpha as new markers for pancreatic acinar cell carcinoma. Hum Pathol. 2020 Sep; 103:120-126 Epub 2020 July 21
    View PubMed
  53. Erickson LA, Torbenson MS. Hepatic Focal Nodular Hyperplasia. Mayo Clin Proc. 2020 Jul; 95 (7):1557-1558
    View PubMed
  54. Torbenson M, Yasir S, Anders R, Guy CD, Lee HE, Venkatesh SK, Wu TT, Chen ZE. Regenerative hepatic pseudotumor: a new pseudotumor of the liver. Hum Pathol. 2020 May; 99:43-52 Epub 2020 Mar 25
    View PubMed
  55. Leiting JL, Murphy SJ, Bergquist JR, Hernandez MC, Ivanics T, Abdelrahman AM, Yang L, Lynch I, Smadbeck JB, Cleary SP, Nagorney DM, Torbenson MS, Graham RP, Roberts LR, Gores GJ, Smoot RL, Truty MJ. Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine. JHEP Rep. 2020 Apr; 2 (2):100068 Epub 2020 Jan 16
    View PubMed
  56. Erickson LA, Torbenson MS. Intestinal Spirochetosis. Mayo Clin Proc. 2020 Feb; 95 (2):427-428
    View PubMed
  57. Balbeur S, Dumortier A, Mergen J, Libbrecht L, Torbenson M, Boulanger C, de Ville de Goyet M, Van Damme A, Brichard B. DNAJB1-PRKACA-positive metastatic fibrolamellar carcinoma with unknown primary in a pediatric patient. Pediatr Blood Cancer. 2020 Feb; 67 (2):e28060 Epub 2019 Nov 17
    View PubMed
  58. Singhi AD, Wood LD, Parks E, Torbenson MS, Felsenstein M, Hruban RH, Nikiforova MN, Wald AI, Kaya C, Nikiforov YE, Favazza L, He J, McGrath K, Fasanella KE, Brand RE, Lennon AM, Furlan A, Dasyam AK, Zureikat AH, Zeh HJ, Lee K, Bartlett DL, Slivka A. Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct. Gastroenterology. 2020 Feb; 158 (3):573-582.e2 Epub 2019 Oct 31
    View PubMed
  59. Olave MC, Gurung A, Mistry PK, Kakar S, Yeh M, Xu M, Wu TT, Torbenson M, Jain D. Etiology of cirrhosis in the young. Hum Pathol. 2020 Feb; 96:96-103 Epub 2019 Nov 05
    View PubMed
  60. Torbenson M, Washington K. Pathology of liver disease: advances in the last 50 years. Hum Pathol. 2020 Jan; 95:78-98 Epub 2019 Sept 04
    View PubMed
  61. Pai RK, Kleiner DE, Hart J, Adeyi OA, Clouston AD, Behling CA, Jain D, Kakar S, Brahmania M, Burgart L, Batts KP, Valasek MA, Torbenson MS, Guindi M, Wang HL, Ajmera V, Adams LA, Parker CE, Feagan BG, Loomba R, Jairath V. Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials. Aliment Pharmacol Ther. 2019 Nov; 50 (10):1100-1111 Epub 2019 Oct 03
    View PubMed
  62. Lunn B, Yasir S, Lam-Himlin D, Menias CO, Torbenson MS, Venkatesh SK. Anastomosing hemangioma of the liver: a case series. Abdom Radiol (NY). 2019 Aug; 44 (8):2781-2787
    View PubMed
  63. Arnold CA, Graham RP, Jain D, Kakar S, Lam-Himlin DM, Naini BV, Wu TT, Yeh MM, Torbenson MS. Knowledge gaps in the appendix: a multi-institutional study from seven academic centers. Mod Pathol. 2019 Jul; 32 (7):988-996 Epub 2019 Feb 14
    View PubMed
  64. Venkatesh SK, Hoodeshenas S, Venkatesh SH, Dispenzieri A, Gertz MA, Torbenson MS, Ehman RL. Magnetic Resonance Elastography of Liver in Light Chain Amyloidosis. J Clin Med. 2019 May 23; 8 (5)
    View PubMed
  65. Torbenson MS, Arnold CA, Graham RP, Jain D, Kakar S, Lam-Himlin DM, Naini BV, Wu TT, Yeh M. Identification of key challenges in liver pathology: data from a multicenter study of extramural consults. Hum Pathol. 2019 May; 87:75-82 Epub 2019 Mar 08
    View PubMed
  66. Yasir S, Torbenson MS. Angiosarcoma of the Liver: Clinicopathologic Features and Morphologic Patterns. Am J Surg Pathol. 2019 May; 43 (5):581-590
    View PubMed
  67. Wilson GC, Lluis N, Nalesnik MA, Nassar A, Serrano T, Ramos E, Torbenson M, Asbun HJ, Geller DA. Hepatic Angiosarcoma: A Multi-institutional, International Experience with 44 Cases. Ann Surg Oncol. 2019 Feb; 26 (2):576-582 Epub 2018 Nov 19
    View PubMed
  68. Torbenson MS. Hamartomas and malformations of the liver. Semin Diagn Pathol. 2019 Jan; 36 (1):39-47 Epub 2018 Nov 17
    View PubMed
  69. Navin PJ, Hilscher MB, Welle CL, Mounajjed T, Torbenson MS, Kamath PS, Venkatesh SK. The Utility of MR Elastography to Differentiate Nodular Regenerative Hyperplasia from Cirrhosis. Hepatology. 2019 Jan; 69 (1):452-454 Epub 2018 Dec 25
    View PubMed
  70. Graham RP, Lackner C, Terracciano L, Gonzalez-Cantu Y, Maleszewski JJ, Greipp PT, Simon SM, Torbenson MS. Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion. Hepatology. 2018 Oct; 68 (4):1441-1447 Epub 2018 May 11
    View PubMed
  71. AlFarkh W, Torbenson MS, Mounajjed T. Benign hepatic lesions arising in accessory hepatic lobes AJSP-Reviews And Reports. 2018 Sep-oct; 23 (5):241-5
  72. Ehman EC, Torbenson MS, Wells ML, Welch BT, Thompson SM, Garg I, Venkatesh SK. Hepatic tumors of vascular origin: imaging appearances. Abdom Radiol (NY). 2018 Aug; 43 (8):1978-1990
    View PubMed
  73. Lee HE, Wu TT, Chandan VS, Torbenson MS, Mounajjed T. Colonic Adenomatous Polyps Involving Submucosal Lymphoglandular Complexes: A Diagnostic Pitfall. Am J Surg Pathol. 2018 Aug; 42 (8):1083-1089
    View PubMed
  74. Torbenson M. Hepatic Adenomas: Classification, Controversies, and Consensus. Surg Pathol Clin. 2018 Jun; 11 (2):351-366 Epub 2018 Mar 26
    View PubMed
  75. Chandan VS, Shah SS, Mounajjed T, Torbenson MS, Wu TT. Copper deposition in focal nodular hyperplasia and inflammatory hepatocellular adenoma. J Clin Pathol. 2018 Jun; 71 (6):504-507 Epub 2017 Nov 10
    View PubMed
  76. Jones D, Manns MP, Terracciano L, Torbenson M, Vierling JM. Unmet needs and new models for future trials in autoimmune hepatitis. Lancet Gastroenterol Hepatol. 2018 May; 3 (5):363-370 Epub 2018 Apr 06
    View PubMed
  77. Knijnenburg TA, Wang L, Zimmermann MT, Chambwe N, Gao GF, Cherniack AD, Fan H, Shen H, Way GP, Greene CS, Liu Y, Akbani R, Feng B, Donehower LA, Miller C, Shen Y, Karimi M, Chen H, Kim P, Jia P, Shinbrot E, Zhang S, Liu J, Hu H, Bailey MH, Yau C, Wolf D, Zhao Z, Weinstein JN, Li L, Ding L, Mills GB, Laird PW, Wheeler DA, Shmulevich I, Monnat RJ Jr, Xiao Y, Wang C, Cancer Genome Atlas Research Network. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep. 2018 Apr 3; 23 (1):239-254.e6
    View PubMed
  78. Campbell JD, Yau C, Bowlby R, Liu Y, Brennan K, Fan H, Taylor AM, Wang C, Walter V, Akbani R, Byers LA, Creighton CJ, Coarfa C, Shih J, Cherniack AD, Gevaert O, Prunello M, Shen H, Anur P, Chen J, Cheng H, Hayes DN, Bullman S, Pedamallu CS, Ojesina AI, Sadeghi S, Mungall KL, Robertson AG, Benz C, Schultz A, Kanchi RS, Gay CM, Hegde A, Diao L, Wang J, Ma W, Sumazin P, Chiu HS, Chen TW, Gunaratne P, Donehower L, Rader JS, Zuna R, Al-Ahmadie H, Lazar AJ, Flores ER, Tsai KY, Zhou JH, Rustgi AK, Drill E, Shen R, Wong CK, Stuart JM, Laird PW, Hoadley KA, Weinstein JN, Peto M, Pickering CR, Chen Z, Van Waes C, Cancer Genome Atlas Research Network. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas. Cell Rep. 2018 Apr 3; 23 (1):194-212.e6
    View PubMed
  79. Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP, Hsieh JJ, Ho TH, Kanchi RS, Krishnan B, Kwiatkowski DJ, Liu W, Lui W, Merino MJ, Mills GB, Myers J, Nickerson ML, Reuter VE, Schmidt LS, Shelley CS, Shen H, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Vincent BG, Vocke CD, Wheeler DA, Yang L, Kim WY, Robertson AG, Spellman PT, Rathmell WK, Linehan WM, Cancer Genome Atlas Research Network. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3; 23 (1):313-326.e5
    View PubMed
  80. Hammond WJ, Lalazar G, Saltsman JA, Farber BA, Danzer E, Sherpa TC, Banda CD, Andolina JR, Karimi S, Brennan CW, Torbenson MS, La Quaglia MP, Simon SM. Intracranial metastasis in fibrolamellar hepatocellular carcinoma. Pediatr Blood Cancer. 2018 Apr; 65 (4) Epub 2017 Dec 29
    View PubMed
  81. Nath MC, Torbenson MS, Erickson LA. Desmoid Tumor. Mayo Clin Proc. 2018 Apr; 93 (4):549-550
    View PubMed
  82. Nath MC, Torbenson MS, Erickson LA. Perihilar Cholangiocarcinoma. Mayo Clin Proc. 2018 Mar; 93 (3):397-398
    View PubMed
  83. Graham RP, Naini BV, Shah SS, Arnold CA, Kannangai R, Torbenson MS, Lam-Himlin DM. Treponema pallidum Immunohistochemistry is positive in human intestinal Spirochetosis. Diagn Pathol. 2018 Jan 22; 13 (1):7
    View PubMed
  84. Graham RP, Yeh MM, Lam-Himlin D, Roberts LR, Terracciano L, Cruise MW, Greipp PT, Zreik RT, Jain D, Zaid N, Salaria SN, Jin L, Wang X, Rustin JG, Kerr SE, Sukov WR, Solomon DA, Kakar S, Waterhouse E, Gill RM, Ferrell L, Alves VA, Nart D, Yilmaz F, Roessler S, Longerich T, Schirmacher P, Torbenson MS. Molecular testing for the clinical diagnosis of fibrolamellar carcinoma. Mod Pathol. 2018 Jan; 31 (1):141-149 Epub 2017 Sept 01
    View PubMed
  85. Kersten CA, Sloey EN, Zhou E, Peng Y, Torbenson MS, Guo Y. Fibrolamellar hepatocellular carcinoma: Exploring molecular mechanisms and differentiation pathways to better understand disease outcomes and prognosis Liver Research. 2017 Dec; 1 (4):187-92
  86. Clark I, Shah SS, Moreira R, Graham RP, Wu TT, Torbenson MS, Chandan V. A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative. Hum Pathol. 2017 Nov; 69:90-95 Epub 2017 Sept 29
    View PubMed
  87. Garg I, Graham RP, VanBuren WM, Goenka AH, Torbenson MS, Venkatesh SK. Hepatic segmental atrophy and nodular elastosis: imaging features. Abdom Radiol (NY). 2017 Oct; 42 (10):2447-2453
    View PubMed
  88. Czeczok TW, Van Arnam JS, Wood LD, Torbenson MS, Mounajjed T. The Almost-Normal Liver Biopsy: Presentation, Clinical Associations, and Outcome. Am J Surg Pathol. 2017 Sep; 41 (9):1247-1253
    View PubMed
  89. Horowitz JM, Venkatesh SK, Ehman RL, Jhaveri K, Kamath P, Ohliger MA, Samir AE, Silva AC, Taouli B, Torbenson MS, Wells ML, Yeh B, Miller FH. Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY). 2017 Aug; 42 (8):2037-2053
    View PubMed
  90. Farshidfar F, Zheng S, Gingras MC, Newton Y, Shih J, Robertson AG, Hinoue T, Hoadley KA, Gibb EA, Roszik J, Covington KR, Wu CC, Shinbrot E, Stransky N, Hegde A, Yang JD, Reznik E, Sadeghi S, Pedamallu CS, Ojesina AI, Hess JM, Auman JT, Rhie SK, Bowlby R, Borad MJ, Zhu AX, Stuart JM, Sander C, Akbani R, Cherniack AD, Deshpande V, Mounajjed T, Foo WC, Torbenson MS, Kleiner DE, Laird PW, Wheeler DA, McRee AJ, Bathe OF, Andersen JB, Bardeesy N, Roberts LR, Kwong LN, Cancer Genome Atlas Network. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. Cell Rep. 2017 Jun 27; 19 (13):2878-2880
    View PubMed
  91. Shah SS, Wu TT, Torbenson MS, Chandan VS. Aberrant CDX2 expression in hepatocellular carcinomas: an important diagnostic pitfall. Hum Pathol. 2017 Jun; 64:13-18 Epub 2017 Jan 13
    View PubMed
  92. Torbenson MS. Morphologic Subtypes of Hepatocellular Carcinoma. Gastroenterol Clin North Am. 2017 Jun; 46 (2):365-391
    View PubMed
  93. Daniel HD, Torbenson M. Transgenic hepatitis B: a new model of HBV infection. Sci Rep. 2017 Jun 1; 7 (1):2610 Epub 2017 June 01
    View PubMed
  94. Graham RP, Craig JR, Jin L, Oliveira AM, Bergquist JR, Truty MJ, Mounajjed T, Greipp PT, Torbenson MS. Environmental exposures as a risk factor for fibrolamellar carcinoma. Mod Pathol. 2017 Jun; 30 (6):892-896 Epub 2017 Mar 03
    View PubMed
  95. Mukewar S, Sharma A, Lackore KA, Enders FT, Torbenson MS, Kamath PS, Roberts LR, Kudva YC. Clinical, Biochemical, and Histopathology Features of Patients With Glycogenic Hepatopathy. Clin Gastroenterol Hepatol. 2017 Jun; 15 (6):927-933 Epub 2016 Dec 30
    View PubMed
  96. Mahadev S, Murray JA, Wu TT, Chandan VS, Torbenson MS, Kelly CP, Maki M, Green PH, Adelman D, Lebwohl B. Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten-free diet. Aliment Pharmacol Ther. 2017 Apr; 45 (8):1084-1093 Epub 2017 Feb 20
    View PubMed
  97. Dinh TA, Vitucci EC, Wauthier E, Graham RP, Pitman WA, Oikawa T, Chen M, Silva GO, Greene KG, Torbenson MS, Reid LM, Sethupathy P. Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma. Sci Rep. 2017 Mar 17; 7:44653
    View PubMed
  98. Farshidfar F, Zheng S, Gingras MC, Newton Y, Shih J, Robertson AG, Hinoue T, Hoadley KA, Gibb EA, Roszik J, Covington KR, Wu CC, Shinbrot E, Stransky N, Hegde A, Yang JD, Reznik E, Sadeghi S, Pedamallu CS, Ojesina AI, Hess JM, Auman JT, Rhie SK, Bowlby R, Borad MJ, Zhu AX, Stuart JM, Sander C, Akbani R, Cherniack AD, Deshpande V, Mounajjed T, Foo WC, Torbenson MS, Kleiner DE, Laird PW, Wheeler DA, McRee AJ, Bathe OF, Andersen JB, Bardeesy N, Roberts LR, Kwong LN, Cancer Genome Atlas Network. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. Cell Rep. 2017 Mar 14; 18 (11):2780-2794
    View PubMed
  99. Graham RP, Torbenson MS. Fibrolamellar carcinoma: A histologically unique tumor with unique molecular findings. Semin Diagn Pathol. 2017 Mar; 34: (2)146-152.
    View PubMed
  100. Clark I, Torbenson MS. Immunohistochemistry and Special Stains in Medical Liver Pathology. Adv Anat Pathol. 2017 Mar; 24: (2)99-109.
    View PubMed
  101. Fritchie KJ, Jin L, Wang X, Graham RP, Torbenson MS, Lewis JE, Rivera M, Garcia JJ, Schembri-Wismayer DJ, Westendorf JJ, Chou MM, Dong J, Oliveira AM. Fusion gene profile of biphenotypic sinonasal sarcoma: an analysis of 44 cases. Histopathology. 2016 Dec; 69 (6):930-936 Epub 2016 Sept 23
    View PubMed
  102. Young JT, Kurup AN, Graham RP, Torbenson MS, Venkatesh SK. Myxoid hepatocellular neoplasms: imaging appearance of a unique mucinous tumor variant. Abdom Radiol (NY). 2016 Nov; 41 (11):2115-2122
    View PubMed
  103. Blackburn PR, Hickey RD, Nace RA, Giama NH, Kraft DL, Bordner AJ, Chaiteerakij R, McCormick JB, Radulovic M, Graham RP, Torbenson MS, Tortorelli S, Scott CR, Lindor NM, Milliner DS, Oglesbee D, Al-Qabandi W, Grompe M, Gavrilov DK, El-Youssef M, Clark KJ, Atwal PS, Roberts LR, Klee EW, Ekker SC. Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma. Hum Mutat. 2016 Oct; 37 (10):1097-105 Epub 2016 Aug 08
    View PubMed
  104. Wang Y, Ding X, Wang S, Moser CD, Shaleh HM, Mohamed EA, Chaiteerakij R, Allotey LK, Chen G, Miyabe K, McNulty MS, Ndzengue A, Barr Fritcher EG, Knudson RA, Greipp PT, Clark KJ, Torbenson MS, Kipp BR, Zhou J, Barrett MT, Gustafson MP, Alberts SR, Borad MJ, Roberts LR. Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein. Cancer Lett. 2016 Sep 28; 380 (1):163-73 Epub 2016 May 20
    View PubMed
  105. Chandan VS, Shah SS, Torbenson MS, Wu TT. Arginase-1 is frequently positive in hepatoid adenocarcinomas. Hum Pathol. 2016 Sep; 55:11-6 Epub 2016 Apr 30
    View PubMed
  106. Liu L, Shah SS, Naini BV, French S, Wu TT, Torbenson MS, Chandan VS. Immunostains Used to Subtype Hepatic Adenomas Do Not Distinguish Hepatic Adenomas From Hepatocellular Carcinomas. Am J Surg Pathol. 2016 Aug; 40 (8):1062-9
    View PubMed
  107. Mahamoud HD, Muse SM, Roberts LR, Fischer PR, Torbenson MS, Fader T. Khat chewing and cirrhosis in Somaliland: Case series. Afr J Prim Health Care Fam Med. 2016 Jul 28; 8 (1):e1-4 Epub 2016 July 28
    View PubMed
  108. Graham RP, Terracciano LM, Meves A, Vanderboom PM, Dasari S, Yeh MM, Torbenson MS, Cruise MW. Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss. Mod Pathol. 2016 Jun; 29 (6):607-15 Epub 2016 Mar 25
    View PubMed
  109. Schafer MJ, White TA, Evans G, Tonne JM, Verzosa GC, Stout MB, Mazula DL, Palmer AK, Baker DJ, Jensen MD, Torbenson MS, Miller JD, Ikeda Y, Tchkonia T, van Deursen JM, Kirkland JL, LeBrasseur NK. Exercise Prevents Diet-Induced Cellular Senescence in Adipose Tissue. Diabetes. 2016 Jun; 65 (6):1606-15 Epub 2016 Mar 16
    View PubMed
  110. Dhanasekaran R, Venkatesh SK, Torbenson MS, Roberts LR. Erratum to "Clinical implications of basic research in hepatocellular carcinoma" [J Hepatol 2016;64:736-745]. J Hepatol. 2016 Jun; 64 (6):1462 Epub 2016 Mar 22
    View PubMed
  111. Lehrke HD, Torbenson MS, Erickson LA. Man With Fever and Severe Diarrhea. Mayo Clin Proc. 2016 Apr; 91 (4):e55-6
    View PubMed
  112. Gupta S, Naini BV, Munoz R, Graham RP, Kipp BR, Torbenson MS, Mounajjed T. Hepatocellular Neoplasms Arising in Association With Androgen Use. Am J Surg Pathol. 2016 Apr; 40: (4)454-61.
    View PubMed
  113. Graham RP, Garcia JJ, Greipp PT, Barr Fritcher EG, Kipp BR, Torbenson MS. FGFR1 and FGFR2 in fibrolamellar carcinoma. Histopathology. 2016 Apr; 68(5):686-92. Epub 2015 Oct 05.
    View PubMed
  114. Dhanasekaran R, Venkatesh SK, Torbenson MS, Roberts LR. Clinical implications of basic research in hepatocellular carcinoma. J Hepatol. 2016 Mar; 64 (3):736-45 Epub 2015 Oct 09
    View PubMed
  115. Yeh MM, Liu Y, Torbenson M. Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study. Hum Pathol. 2015 Nov; 46 (11):1769-75 Epub 2015 Aug 04
    View PubMed
  116. Leyva F, Fuchs EJ, Bakshi R, Carballo-Dieguez A, Ventuneac A, Yue C, Caffo B, Du Y, Torbenson M, Li L, Mullin G, Lee L, Rohan L, Anton PA, Hendrix CW. Simultaneous Evaluation of Safety, Acceptability, Pericoital Kinetics, and Ex Vivo Pharmacodynamics Comparing Four Rectal Microbicide Vehicle Candidates. AIDS Res Hum Retroviruses. 2015 Nov; 31 (11):1089-97 Epub 2015 July 08
    View PubMed
  117. Mesarwi OA, Shin MK, Drager LF, Bevans-Fonti S, Jun JC, Putcha N, Torbenson MS, Pedrosa RP, Lorenzi-Filho G, Steele KE, Schweitzer MA, Magnuson TH, Lidor AO, Schwartz AR, Polotsky VY. Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea. Sleep. 2015 Oct 1; 38 (10):1583-91 Epub 2015 Oct 01
    View PubMed
  118. Mounajjed T, Yasir S, Aleff PA, Torbenson MS. Pigmented hepatocellular adenomas have a high risk of atypia and malignancy. Mod Pathol. 2015 Sep; 28 (9):1265-74 Epub 2015 July 24
    View PubMed
  119. Nguyen T, Phillips D, Jain D, Torbenson M, Wu TT, Yeh MM, Kakar S. Comparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma. Arch Pathol Lab Med. 2015 Aug; 139(8):1028-34.
    View PubMed
  120. Graham RP, Jin L, Knutson DL, Kloft-Nelson SM, Greipp PT, Waldburger N, Roessler S, Longerich T, Roberts LR, Oliveira AM, Halling KC, Schirmacher P, Torbenson MS. DNAJB1-PRKACA is specific for fibrolamellar carcinoma. Mod Pathol. 2015 Jun; 28(6):822-9. Epub 2015 Feb 20.
    View PubMed
  121. Hourigan SK, Torbenson M, Tibesar E, Scheimann AO. The full spectrum of hepatic steatosis in children. Clin Pediatr (Phila). 2015 Jun; 54: (7)635-42.
    View PubMed
  122. Chandan VS, Shah SS, Lam-Himlin DM, Petris GD, Mereuta OM, Dogan A, Torbenson MS, Wu TT. Globular hepatic amyloid is highly sensitive and specific for LECT2 amyloidosis. Am J Surg Pathol. 2015 Apr; 39(4):558-64.
    View PubMed
  123. Salaria SN, Graham RP, Aishima S, Mounajjed T, Yeh MM, Torbenson MS. Primary hepatic tumors with myxoid change: morphologically unique hepatic adenomas and hepatocellular carcinomas. Am J Surg Pathol. 2015 Mar; 39 (3):318-24
    View PubMed
  124. Hourigan SK, Abrams S, Yates K, Pfeifer K, Torbenson M, Murray K, Roth CL, Kowdley K, Scheimann AO, NASH CRN. Relation between vitamin D status and nonalcoholic fatty liver disease in children. J Pediatr Gastroenterol Nutr. 2015 Mar; 60 (3):396-404
    View PubMed
  125. Knabel MK, Ramachandran K, Karhadkar S, Hwang HW, Creamer TJ, Chivukula RR, Sheikh F, Clark KR, Torbenson M, Montgomery RA, Cameron AM, Mendell JT, Warren DS. Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice. PLoS One. 2015; 10 (4):e0124411 Epub 2015 Apr 29
    View PubMed
  126. Graham RP, Torbenson MS. Fibrolamellar carcinoma: Diagnosis and diagnostic pitfalls. Pathology Case Reviews. 2014; 19(6):309-15.
  127. Brunt EM, Gouw ASH, Hubscher SG, Tiniakos DG, Bedossa P, Burt AD, Callea F, Clouston AD, Dienes HP, Goodman ZD, Roberts EA, Roskams T, Terracciano L, Torbenson MS, Wanless IR. Pathology of the liver sinusoids. Histopathology. 2014; 64(7):907-20.
    View PubMed
  128. Joseph NM, Ferrell LD, Jain D, Torbenson MS, Wu TT, Yeh MM, Kakar S. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma. Mod Pathol. 2014 Jan; 27 (1):62-72 Epub 2013 June 28
    View PubMed
  129. Wood LD, Heaphy CM, Daniel HD, Naini BV, Lassman CR, Arroyo MR, Kamel IR, Cosgrove DP, Boitnott JK, Meeker AK, Torbenson MS. Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features. Mod Pathol. 2013 Dec; 26(12):1586-93. Epub 2013 May 03.
    View PubMed
  130. Mathai AM, Alexander J, Kuo FY, Torbenson M, Swanson PE, Yeh MM. Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B. Hum Pathol. 2013 Aug; 44(8):1665-71. Epub 2013 Apr 08.
    View PubMed
  131. Gonzalez-Roibon N, Katz B, Chaux A, Sharma R, Munari E, Faraj SF, Illei PB, Torbenson M, Netto GJ. Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors. Hum Pathol. 2013 Jul; 44(7):1293-9. Epub 2013 Jan 21.
    View PubMed
  132. Krings G, Ramachandran R, Jain D, Wu TT, Yeh MM, Torbenson M, Kakar S. Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma. Mod Pathol. 2013 Jun; 26(6):782-91. Epub 2013 Jan 25.
    View PubMed
  133. Alexander J, Torbenson M, Wu TT, Yeh MM. Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study. J Gastroenterol Hepatol. 2013 May; 28(5):848-54.
    View PubMed
  134. Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA Jr, Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He Y, Hruban RH, Jallo GI, Mandahl N, Meeker AK, Mertens F, Netto GJ, Rasheed BA, Riggins GJ, Rosenquist TA, Schiffman M, Shih IeM, Theodorescu D, Torbenson MS, Velculescu VE, Wang TL, Wentzensen N, Wood LD, Zhang M, McLendon RE, Bigner DD, Kinzler KW, Vogelstein B, Papadopoulos N, Yan H. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A. 2013 Apr 9; 110(15):6021-6. Epub 2013 Mar 25.
    View PubMed
  135. Zheng G, Martignoni G, Antonescu C, Montgomery E, Eberhart C, Netto G, Taube J, Westra W, Epstein JI, Lotan T, Maitra A, Gabrielson E, Torbenson M, Iacobuzio-Donahue C, Demarzo A, Shih IeM, Illei P, Wu TC, Argani P. A broad survey of cathepsin K immunoreactivity in human neoplasms. Am J Clin Pathol. 2013 Feb; 139(2):151-9.
    View PubMed
  136. El-Maouche D, Mehta SH, Sutcliffe CG, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS, Brown TT. Vitamin D deficiency and its relation to bone mineral density and liver fibrosis in HIV-HCV coinfection. Antivir Ther. 2013; 18(2):237-42. Epub 2012 Aug 07.
    View PubMed
  137. Petersen SM, Gendelman M, Murphy KM, Torbenson M, Jones RJ, Stetten G, Bird C, Blakemore KJ. In utero hematopoietic stem cell transplantation in canines: exploring the gestational age window of opportunity to maximize engraftment. Fetal Diagn Ther. 2013; 33(2):116-21. Epub 2013 Jan 19.
    View PubMed
  138. Ang CS, Kelley RK, Choti MA, Cosgrove DP, Chou JF, Klimstra D, Torbenson MS, Ferrell L, Pawlik TM, Fong Y, O'Reilly EM, Ma J, McGuire J, Vallarapu GP, Griffin A, Stipa F, Capanu M, Dematteo RP, Venook AP, Abou-Alfa GK. Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. Gastrointest Cancer Res. 2013 Jan; 6(1):3-9.
    View PubMed
  139. Balabaud C, Al-Rabih WR, Chen PJ, Evason K, Ferrell L, Hernandez-Prera JC, Huang SF, Longerich T, Park YN, Quaglia A, Schirmacher P, Sempoux C, Thung SN, Torbenson M, Wee A, Yeh MM, Yeh SH, Le Bail B, Zucman-Rossi J, Bioulac-Sage P. Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification. Int J Hepatol. 2013; 2013:268625. Epub 2013 Apr 14.
    View PubMed
  140. Wild AT, Gandhi N, Chettiar ST, Aziz K, Gajula RP, Williams RD, Kumar R, Taparra K, Zeng J, Cades JA, Velarde E, Menon S, Geschwind JF, Cosgrove D, Pawlik TM, Maitra A, Wong J, Hales RK, Torbenson MS, Herman JM, Tran PT. Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma. PLoS One. 2013; 8(6):e65726. Epub 2013 Jun 06.
    View PubMed
  141. Wang MH, Okazaki T, Kugathasan S, Cho JH, Isaacs KL, Lewis JD, Smoot DT, Valentine JF, Kader HA, Ford JG, Harris ML, Oliva-Hemker M, Cuffari C, Torbenson MS, Duerr RH, Silverberg MS, Rioux JD, Taylor KD, Nguyen GC, Wu Y, Datta LW, Hooker S, Dassopoulos T, Kittles RA, Kao LW, Brant SR. Contribution of higher risk genes and European admixture to Crohn's disease in African Americans. Inflamm Bowel Dis. 2012 Dec; 18(12):2277-87. Epub 2012 Mar 12.
    View PubMed
  142. Liu TC, Nguyen TT, Torbenson MS. Concurrent increase in mitosis and apoptosis: a histological pattern of hepatic arterial flow abnormalities in post-transplant liver biopsies. Mod Pathol. 2012 Dec; 25(12):1594-8. Epub 2012 Jul 06.
    View PubMed
  143. Munshaw S, Hwang HS, Torbenson M, Quinn J, Hansen KD, Astemborski J, Mehta SH, Ray SC, Thomas DL, Balagopal A. Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug users. Hepatology. 2012 Aug; 56(2):544-54. Epub 2012 Jul 6
    View PubMed
  144. Limketkai BN, Mehta SH, Sutcliffe CG, Higgins YM, Torbenson MS, Brinkley SC, Moore RD, Thomas DL, Sulkowski MS. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. JAMA. 2012 Jul 25; 308(4):370-8.
    View PubMed
  145. Yamanaka S, Olaru AV, An F, Luvsanjav D, Jin Z, Agarwal R, Tomuleasa C, Popescu I, Alexandrescu S, Dima S, Chivu-Economescu M, Montgomery EA, Torbenson M, Meltzer SJ, Selaru FM. MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer. Dig Liver Dis. 2012 Jul; 44(7):589-96. Epub 2012 Mar 28.
    View PubMed
  146. O'Donnell KA, Keng VW, York B, Reineke EL, Seo D, Fan D, Silverstein KA, Schrum CT, Xie WR, Mularoni L, Wheelan SJ, Torbenson MS, O'Malley BW, Largaespada DA, Boeke JD. A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer. Proc Natl Acad Sci U S A. 2012 May 22; 109(21):E1377-86. Epub 2012 May 3
    View PubMed
  147. Singhi AD, Jain D, Kakar S, Wu TT, Yeh MM, Torbenson M. Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma. Am J Surg Pathol. 2012 May; 36(5):710-5.
    View PubMed
  148. Roy A, Wang C, Li C, Lu L, Torbenson M, Hagedorn CH, Schwarz KB. Phenotypic and genotypic differences between a child with vertically acquired severe hepatitis C liver disease and his mother. J Pediatr Gastroenterol Nutr. 2012 Apr; 54(4):567-9.
    View PubMed
  149. Guerrerio AL, Colvin RM, Schwartz AK, Molleston JP, Murray KF, Diehl A, Mohan P, Schwimmer JB, Lavine JE, Torbenson MS, Scheimann AO. Choline intake in a large cohort of patients with nonalcoholic fatty liver disease. Am J Clin Nutr. 2012 Apr; 95(4):892-900. Epub 2012 Feb 15.
    View PubMed
  150. Ganapathy-Kanniappan S, Kunjithapatham R, Torbenson MS, Rao PP, Carson KA, Buijs M, Vali M, Geschwind JF. Human hepatocellular carcinoma in a mouse model: assessment of tumor response to percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists. Radiology. 2012 Mar; 262(3):834-45.
    View PubMed
  151. Louissaint NA, Nimmagadda S, Fuchs EJ, Bakshi RP, Cao YJ, Lee LA, Goldsmith J, Caffo BS, Du Y, King KE, Menendez FA, Torbenson MS, Hendrix CW. Distribution of cell-free and cell-associated HIV surrogates in the colon after simulated receptive anal intercourse in men who have sex with men. J Acquir Immune Defic Syndr. 2012 Jan 1; 59(1):10-7.
    View PubMed
  152. Thompson AJ, Patel K, Chuang WL, Lawitz EJ, Rodriguez-Torres M, Rustgi VK, Flisiak R, Pianko S, Diago M, Arora S, Foster GR, Torbenson M, Benhamou Y, Nelson DR, Sulkowski MS, Zeuzem S, Pulkstenis E, Subramanian GM, McHutchison JG, ACHIEVE-1 and ACHIEVE-2/3 Study Teams. Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3. Gut. 2012 Jan; 61(1):128-34. Epub 2011 Aug 26.
    View PubMed
  153. Torbenson M. Fibrolamellar carcinoma: 2012 update. Scientifica. 2012.
  154. Olaru AV, Ghiaur G, Yamanaka S, Luvsanjav D, An F, Popescu I, Alexandrescu S, Allen S, Pawlik TM, Torbenson M, Georgiades C, Roberts LR, Gores GJ, Ferguson-Smith A, Almeida MI, Calin GA, Mezey E, Selaru FM. MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint. Hepatology. 2011 Dec; 54(6):2089-98.
    View PubMed
  155. Patel K, Friedrich-Rust M, Lurie Y, Grigorescu M, Stanciu C, Lee CM, Schiff ER, Haussinger D, Manns MP, Gerken G, Colle I, Torbenson M, Pulkstenis E, Subramanian GM, McHutchison JG, Zeuzem S. FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus. World J Gastroenterol. 2011 Nov 7; 17(41):4581-9.
    View PubMed
  156. Bonekamp S, Torbenson MS, Kamel IR. Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis. J Clin Gastroenterol. 2011 Nov-Dec; 45(10):885-92.
    View PubMed
  157. Zhao H, Wang J, Han Y, Huang Z, Ying J, Bi X, Zhao J, Fang Y, Zhou H, Zhou J, Li Z, Zhang Y, Yang X, Yan T, Wang L, Torbenson MS, Cai J. ARID2: a new tumor suppressor gene in hepatocellular carcinoma. Oncotarget. 2011 Nov; 2(11):886-91.
    View PubMed
  158. El-Maouche D, Mehta SH, Sutcliffe C, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS, Brown TT. Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection. J Hepatol. 2011 Oct; 55(4):770-6. Epub 2011 Feb 19.
    View PubMed
  159. Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E, Netto GJ, Epstein JI, Lotan TL, Westra WH, Shih IeM, Iacobuzio-Donahue CA, Maitra A, Li QK, Eberhart CG, Taube JM, Rakheja D, Kurman RJ, Wu TC, Roden RB, Argani P, De Marzo AM, Terracciano L, Torbenson M, Meeker AK. Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol. 2011 Oct; 179(4):1608-15. Epub 2011 Sep 1
    View PubMed
  160. Li M, Zhao H, Zhang X, Wood LD, Anders RA, Choti MA, Pawlik TM, Daniel HD, Kannangai R, Offerhaus GJ, Velculescu VE, Wang L, Zhou S, Vogelstein B, Hruban RH, Papadopoulos N, Cai J, Torbenson MS, Kinzler KW. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet. 2011 Sep; 43(9):828-9. Epub 2011 Aug 07.
    View PubMed
  161. Torbenson M. Iron in the liver: a review for surgical pathologists. Adv Anat Pathol. 2011 Jul; 18(4):306-17.
    View PubMed
  162. Jiang X, Leong D, Ren Y, Li Z, Torbenson MS, Mao HQ. String-like micellar nanoparticles formed by complexation of PEG-b-PPA and plasmid DNA and their transfection efficiency. Pharm Res. 2011 Jun; 28(6):1317-27. Epub 2011 Apr 16.
    View PubMed
  163. Holdhoff M, Schmidt K, Diehl F, Aggrawal N, Angenendt P, Romans K, Edelstein DL, Torbenson M, Kinzler KW, Vogelstein B, Choti MA, Diaz LA. Detection of tumor DNA at the margins of colorectal cancer liver metastasis. Clin Cancer Res. 2011 Jun 1; 17(11):3551-7. Epub 2011 Apr 29.
    View PubMed
  164. Singhi AD, Adsay NV, Swierczynski SL, Torbenson M, Anders RA, Hruban RH, Argani P. Hyperplastic Luschka ducts: a mimic of adenocarcinoma in the gallbladder fossa. Am J Surg Pathol. 2011 Jun; 35(6):883-90.
    View PubMed
  165. Drebber U, Torbenson M, Wedemeyer I, Dienes HP. [Current aspects of liver allograft pathology]. Pathologe. 2011 Mar; 32(2):113-23.
    View PubMed
  166. Vivekanandan P, Torbenson M, Ramakrishna B. Hepatitis B virus-associated hepatocellular carcinoma from India: role of viral genotype and mutations in CTNNB1 (beta-catenin) and TP53 genes. J Gastrointest Cancer. 2011 Mar; 42(1):20-5.
    View PubMed
  167. Woreta TA, Sutcliffe CG, Mehta SH, Brown TT, Higgins Y, Thomas DL, Torbenson MS, Moore RD, Sulkowski MS. Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus. Gastroenterology. 2011 Mar; 140(3):809-17. Epub 2010 Dec 04.
    View PubMed
  168. Singhi AD, Maklouf HR, Mehrotra AK, Goodman ZD, Drebber U, Dienes HP, Torbenson M. Segmental atrophy of the liver: a distinctive pseudotumor of the liver with variable histologic appearances. Am J Surg Pathol. 2011 Mar; 35(3):364-71.
    View PubMed
  169. Ross HM, Daniel HD, Vivekanandan P, Kannangai R, Yeh MM, Wu TT, Makhlouf HR, Torbenson M. Fibrolamellar carcinomas are positive for CD68. Mod Pathol. 2011 Mar; 24(3):390-5. Epub 2010 Nov 26
    View PubMed
  170. Kemp CD, Arnold CA, Torbenson MS, Stein EM. An unusual polyp: a pedunculated leiomyoma of the sigmoid colon. Endoscopy. 2011; 43 Suppl 2 UCTN:E306-7. Epub 2011 Sep 13.
    View PubMed
  171. Torbenson M, Hart J, Westerhoff M, Azzam RK, Elgendi A, Mziray-Andrew HC, Kim GE, Scheimann A. Neonatal giant cell hepatitis: histological and etiological findings. Am J Surg Pathol. 2010 Oct; 34(10):1498-503.
    View PubMed
  172. van Vledder MG, Torbenson MS, Pawlik TM, Boctor EM, Hamper UM, Olino K, Choti MA. The effect of steatosis on echogenicity of colorectal liver metastases on intraoperative ultrasonography. Arch Surg. 2010 Jul; 145(7):661-7.
    View PubMed
  173. Vivekanandan P, Daniel H, Yeh MM, Torbenson M. Mitochondrial mutations in hepatocellular carcinomas and fibrolamellar carcinomas. Mod Pathol. 2010 Jun; 23(6):790-8. Epub 2010 Mar 12.
    View PubMed
  174. Vivekanandan P, Daniel HD, Kannangai R, Martinez-Murillo F, Torbenson M. Hepatitis B virus replication induces methylation of both host and viral DNA. J Virol. 2010 May; 84(9):4321-9. Epub 2010 Feb 10.
    View PubMed
  175. Lam M, Torbenson M, Yeh MM, Vivekanandan P, Ferrell L. HFE mutations in alpha-1-antitrypsin deficiency: an examination of cirrhotic explants. Mod Pathol. 2010 May; 23(5):637-43. Epub 2010 Mar 05.
    View PubMed
  176. Brown TT, Mehta SH, Sutcliffe C, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS. Hepatic steatosis associated with increased central body fat by dual-energy X-ray absorptiometry and uncontrolled HIV in HIV/hepatitis C co-infected persons. AIDS. 2010 Mar 27; 24(6):811-7.
    View PubMed
  177. Yeh MM, Daniel HD, Torbenson M. Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers. Mod Pathol. 2010 Feb; 23(2):276-83. Epub 2009 Nov 20.
    View PubMed
  178. Lee J, Wang J, Torbenson M, Lu Y, Liu QZ, Li S. Loss of SDHB and NF1 genes in a malignant phyllodes tumor of the breast as detected by oligo-array comparative genomic hybridization. Cancer Genet Cytogenet. 2010 Jan 15; 196(2):179-83.
    View PubMed
  179. Ding M, Potter JJ, Liu X, Torbenson MS, Mezey E. Selenium supplementation decreases hepatic fibrosis in mice after chronic carbon tetrachloride administration. Biol Trace Elem Res. 2010 Jan; 133(1):83-97. Epub 2009 Jun 02.
    View PubMed
  180. Torbenson M. Glycogenic Hepatology. Pathology Case Reviews. 2010; 15(3):72-76.
  181. Balagopal A, Ray SC, De Oca RM, Sutcliffe CG, Vivekanandan P, Higgins Y, Mehta SH, Moore RD, Sulkowski MS, Thomas DL, Torbenson MS. Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution. AIDS. 2009 Nov 27; 23(18):2397-404.
    View PubMed
  182. Reyes DK, Vossen JA, Kamel IR, Azad NS, Wahlin TA, Torbenson MS, Choti MA, Geschwind JF. Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J. 2009 Nov-Dec; 15(6):526-32.
    View PubMed
  183. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009 Jun 12; 137(6):1005-17.
    View PubMed
  184. Vivekanandan P, Thomas D, Torbenson M. Methylation regulates hepatitis B viral protein expression. J Infect Dis. 2009 May 1; 199(9):1286-91.
    View PubMed
  185. Selaru FM, Olaru AV, Kan T, David S, Cheng Y, Mori Y, Yang J, Paun B, Jin Z, Agarwal R, Hamilton JP, Abraham J, Georgiades C, Alvarez H, Vivekanandan P, Yu W, Maitra A, Torbenson M, Thuluvath PJ, Gores GJ, LaRusso NF, Hruban R, Meltzer SJ. MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology. 2009 May; 49(5):1595-601.
    View PubMed
  186. Fenton H, Torbenson M, Vivekanandan P, Yeh MM, Hart J, Ferrell L. Marked iron in liver explants in the absence of major hereditary hemochromatosis gene defects: a risk factor for cardiac failure. Transplantation. 2009 Apr 27; 87(8):1256-60.
    View PubMed
  187. Kirk GD, Astemborski J, Mehta SH, Spoler C, Fisher C, Allen D, Higgins Y, Moore RD, Afdhal N, Torbenson M, Sulkowski M, Thomas DL. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clin Infect Dis. 2009 Apr 1; 48(7):963-72.
    View PubMed
  188. Daniels JA, Torbenson M, Vivekanandan P, Anders RA, Boitnott JK. Hepatitis in common variable immunodeficiency. Hum Pathol. 2009 Apr; 40(4):484-8. Epub 2008 Dec 11.
    View PubMed
  189. Aram G, Potter JJ, Liu X, Wang L, Torbenson MS, Mezey E. Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration. Hepatology. 2009 Mar; 49(3):911-9.
    View PubMed
  190. Vivekanandan P, Micchelli ST, Torbenson M. Anterior gradient-2 is overexpressed by fibrolamellar carcinomas. Hum Pathol. 2009 Mar; 40(3):293-9. Epub 2008 Oct 29.
    View PubMed
  191. Patel K, Benhamou Y, Yoshida EM, Kaita KD, Zeuzem S, Torbenson M, Pulkstenis E, Subramanian GM, McHutchison JG. An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C. J Viral Hepat. 2009 Mar; 16(3):178-86. Epub 2008 Oct 24.
    View PubMed
  192. Savransky V, Reinke C, Jun J, Bevans-Fonti S, Nanayakkara A, Li J, Myers AC, Torbenson MS, Polotsky VY. Chronic intermittent hypoxia and acetaminophen induce synergistic liver injury in mice. Exp Physiol. 2009 Feb; 94(2):228-39. Epub 2008 Nov 21.
    View PubMed
  193. Polotsky VY, Patil SP, Savransky V, Laffan A, Fonti S, Frame LA, Steele KE, Schweizter MA, Clark JM, Torbenson MS, Schwartz AR. Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity. Am J Respir Crit Care Med. 2009 Feb 1; 179(3):228-34. Epub 2008 Oct 31
    View PubMed
  194. Daniels JA, Torbenson M, Anders RA, Boitnott JK. Immunostaining of plasma cells in primary biliary cirrhosis. Am J Clin Pathol. 2009 Feb; 131(2):243-9.
    View PubMed
  195. Ready T, Johnson E, Torbenson M, Aufderheide A. Overmodeled skulls from North America. Overmodeled skulls. 2009.
  196. Chaerkady R, Harsha HC, Nalli A, Gucek M, Vivekanandan P, Akhtar J, Cole RN, Simmers J, Schulick RD, Singh S, Torbenson M, Pandey A, Thuluvath PJ. A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma. J Proteome Res. 2008 Oct; 7 (10):4289-98 Epub 2008 Aug 21
    View PubMed
  197. Lee KH, Liapi E, Vossen JA, Buijs M, Ventura VP, Georgiades C, Hong K, Kamel I, Torbenson MS, Geschwind JF. Distribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy. J Vasc Interv Radiol. 2008 Oct; 19(10):1490-6. Epub 2008 Aug 27
    View PubMed
  198. Micchelli ST, Thomas D, Boitnott JK, Torbenson M. Hepatic giant cells in hepatitis C virus (HCV) mono-infection and HCV/HIV co-infection. J Clin Pathol. 2008 Sep; 61(9):1058-61. Epub 2008 Aug 04.
    View PubMed
  199. Chaerkady R, Thuluvath PJ, Kim MS, Nalli A, Vivekanandan P, Simmers J, Torbenson M, Pandey A. O Labeling for a Quantitative Proteomic Analysis of Glycoproteins in Hepatocellular Carcinoma. Clin Proteomics. 2008 Jul 18; 4 (3-4):137-155
    View PubMed
  200. Vivekanandan P, Torbenson M. Epigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas. Mod Pathol. 2008 Jun; 21(6):670-5. Epub 2008 Feb 08.
    View PubMed
  201. Aram G, Potter JJ, Liu X, Torbenson MS, Mezey E. Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration. Hepatology. 2008 Jun; 47(6):2051-8.
    View PubMed
  202. Vivekanandan P, Kannangai R, Ray SC, Thomas DL, Torbenson M. Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples. Clin Infect Dis. 2008 Apr 15; 46(8):1227-36.
    View PubMed
  203. Micchelli ST, Vivekanandan P, Boitnott JK, Pawlik TM, Choti MA, Torbenson M. Malignant transformation of hepatic adenomas. Mod Pathol. 2008 Apr; 21(4):491-7. Epub 2008 Feb 01.
    View PubMed
  204. Vivekanandan P, Thomas D, Torbenson M. Hepatitis B viral DNA is methylated in liver tissues. J Viral Hepat. 2008 Feb; 15(2):103-7.
    View PubMed
  205. Vivekanandan P, Torbenson M. Low frequency of Helicobacter DNA in benign and malignant liver tissues from Baltimore, United States. Hum Pathol. 2008 Feb; 39(2):213-6. Epub 2007 Oct 18.
    View PubMed
  206. Ma X, Torbenson M, Hamad AR, Soloski MJ, Li Z. High-fat diet modulates non-CD1d-restricted natural killer T cells and regulatory T cells in mouse colon and exacerbates experimental colitis. Clin Exp Immunol. 2008 Jan; 151(1):130-8. Epub 2007 Nov 07.
    View PubMed
  207. Verma S, Torbenson M, Thuluvath PJ. The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology. 2007 Dec; 46(6):1828-35.
    View PubMed
  208. Johnson K, Kotiesh A, Boitnott JK, Torbenson M. Histology of symptomatic acute hepatitis C infection in immunocompetent adults. Am J Surg Pathol. 2007 Nov; 31(11):1754-8.
    View PubMed
  209. Sulkowski MS, Mehta SH, Torbenson MS, Higgins Y, Brinkley SC, de Oca RM, Moore RD, Afdhal NH, Thomas DL. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults. AIDS. 2007 Oct 18; 21(16):2209-16.
    View PubMed
  210. Jiang X, Dai H, Ke CY, Mo X, Torbenson MS, Li Z, Mao HQ. PEG-b-PPA/DNA micelles improve transgene expression in rat liver through intrabiliary infusion. J Control Release. 2007 Oct 8; 122(3):297-304. Epub 2007 Jun 22.
    View PubMed
  211. Savransky V, Bevans S, Nanayakkara A, Li J, Smith PL, Torbenson MS, Polotsky VY. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol. 2007 Oct; 293(4):G871-7. Epub 2007 Aug 09.
    View PubMed
  212. Torbenson M, Yeh MM, Abraham SC. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis. Am J Surg Pathol. 2007 Sep; 31(9):1410-3.
    View PubMed
  213. Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg. 2007 Jul; 11(7):860-8.
    View PubMed
  214. Wang XH, Netski DM, Astemborski J, Mehta SH, Torbenson MS, Thomas DL, Ray SC. Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution. J Virol. 2007 Jun; 81(12):6513-22. Epub 2007 Feb 28.
    View PubMed
  215. Kannangai R, Vivekanandan P, Netski D, Mehta S, Kirk GD, Thomas DL, Torbenson M. Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection. J Clin Virol. 2007 Jun; 39(2):101-5. Epub 2007 Apr 23.
    View PubMed
  216. Torbenson M. Review of the clinicopathologic features of fibrolamellar carcinoma. Adv Anat Pathol. 2007 May; 14(3):217-23.
    View PubMed
  217. Krok KL, Torbenson MS, Schulick RD, Thuluvath PJ. Lymphadenopathy, elevated liver function tests and weight loss in a 68-year-old man. J Dig Dis. 2007 May; 8(2):103-6.
    View PubMed
  218. Kannangai R, Vivekanandan P, Martinez-Murillo F, Choti M, Torbenson M. Fibrolamellar carcinomas show overexpression of genes in the RAS, MAPK, PIK3, and xenobiotic degradation pathways. Hum Pathol. 2007 Apr; 38(4):639-44.
    View PubMed
  219. Savransky V, Nanayakkara A, Vivero A, Li J, Bevans S, Smith PL, Torbenson MS, Polotsky VY. Chronic intermittent hypoxia predisposes to liver injury. Hepatology. 2007 Apr; 45(4):1007-13.
    View PubMed
  220. Fuchs EJ, Lee LA, Torbenson MS, Parsons TL, Bakshi RP, Guidos AM, Wahl RL, Hendrix CW. Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission. J Infect Dis. 2007 Mar 1; 195(5):703-10. Epub 2007 Jan 23.
    View PubMed
  221. Kobeiter H, Georgiades CS, Leakakos T, Torbenson M, Hong K, Geschwind JF. Targeted transarterial therapy of Vx-2 rabbit liver tumor with Yttrium-90 labeled ferromagnetic particles using an external magnetic field. Anticancer Res. 2007 Mar-Apr; 27(2):755-60.
    View PubMed
  222. Dorfman JD, Schulick R, Choti MA, Geschwind JF, Kamel I, Torbenson M, Thuluvath PJ. Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States. World J Gastroenterol. 2007 Feb 7; 13(5):781-4.
    View PubMed
  223. Petersen SM, Gendelman M, Murphy KM, Torbenson M, Jones RJ, Althaus JE, Stetten G, Bird C, Blakemore KJ. Use of T-cell antibodies for donor dosaging in a canine model of in utero hematopoietic stem cell transplantation. Fetal Diagn Ther. 2007; 22(3):175-9. Epub 2007 Jan 16.
    View PubMed
  224. Vali M, Liapi E, Kowalski J, Hong K, Khwaja A, Torbenson MS, Georgiades C, Geschwind JF. Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer. J Vasc Interv Radiol. 2007 Jan; 18(1 Pt 1):95-101.
    View PubMed
  225. Torbenson M, Erlen J. A quantitative profile of the patent medicine industry in Baltimore from 1863 to 1930. Pharm Hist. 2007; 49(1):15-27.
    View PubMed
  226. Torbenson M, Barker N. Selling the cure: images of health and disease in early American patent medicine advertisement. Journal of Biocommunications. 2007; 33(3):47-53.
  227. Mehta SH, Lucas GM, Mirel LB, Torbenson M, Higgins Y, Moore RD, Thomas DL, Sulkowski MS. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic. AIDS. 2006 Nov 28; 20(18):2361-9.
    View PubMed
  228. Kannangai R, Sahin F, Torbenson MS. EGFR is phosphorylated at Ty845 in hepatocellular carcinoma. Mod Pathol. 2006 Nov; 19(11):1456-61. Epub 2006 Aug 25.
    View PubMed
  229. Jevremovic D, Torbenson M, Murray JA, Burgart LJ, Abraham SC. Atrophic autoimmune pangastritis: A distinctive form of antral and fundic gastritis associated with systemic autoimmune disease. Am J Surg Pathol. 2006 Nov; 30(11):1412-9.
    View PubMed
  230. Maheshwari A, Torbenson MS, Thuluvath PJ. Sirolimus monotherapy versus sirolimus in combination with steroids and/or MMF for immunosuppression after liver transplantation. Dig Dis Sci. 2006 Oct; 51(10):1677-84.
    View PubMed
  231. Perumal V, Wang J, Thuluvath P, Choti M, Torbenson M. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol. 2006 Sep; 37(9):1211-6. Epub 2006 Jul 18.
    View PubMed
  232. Wisell J, Boitnott J, Haas M, Anders RA, Hart J, Lewis JT, Abraham SC, Torbenson M. Glycogen pseudoground glass change in hepatocytes. Am J Surg Pathol. 2006 Sep; 30(9):1085-90.
    View PubMed
  233. Brastianos PK, Swanson JW, Torbenson M, Sperati J, Karakousis PC. Tuberculosis-associated haemophagocytic syndrome. Lancet Infect Dis. 2006 Jul; 6(7):447-54.
    View PubMed
  234. Xu X, Kobayashi S, Qiao W, Li C, Xiao C, Radaeva S, Stiles B, Wang RH, Ohara N, Yoshino T, LeRoith D, Torbenson MS, Gores GJ, Wu H, Gao B, Deng CX. Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice. J Clin Invest. 2006 Jul; 116(7):1843-52. Epub 2006 Jun 08.
    View PubMed
  235. Hong K, Khwaja A, Liapi E, Torbenson MS, Georgiades CS, Geschwind JF. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res. 2006 Apr 15; 12(8):2563-7.
    View PubMed
  236. Sicklick JK, Li YX, Jayaraman A, Kannangai R, Qi Y, Vivekanandan P, Ludlow JW, Owzar K, Chen W, Torbenson MS, Diehl AM. Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis. Carcinogenesis. 2006 Apr; 27(4):748-57. Epub 2005 Dec 08.
    View PubMed
  237. Wilson LE, Torbenson M, Astemborski J, Faruki H, Spoler C, Rai R, Mehta S, Kirk GD, Nelson K, Afdhal N, Thomas DL. Progression of liver fibrosis among injection drug users with chronic hepatitis C. Hepatology. 2006 Apr; 43(4):788-95.
    View PubMed
  238. Torbenson M, Chen YY, Brunt E, Cummings OW, Gottfried M, Jakate S, Liu YC, Yeh MM, Ferrell L. Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus. Am J Surg Pathol. 2006 Apr; 30(4):508-13.
    View PubMed
  239. Solga SF, Alkhuraishe A, Cope K, Tabesh A, Clark JM, Torbenson M, Schwartz P, Magnuson T, Diehl AM, Risby TH. Breath biomarkers and non-alcoholic fatty liver disease: preliminary observations. Biomarkers. 2006 Mar-Apr; 11(2):174-83.
    View PubMed
  240. Dai H, Jiang X, Tan GC, Chen Y, Torbenson M, Leong KW, Mao HQ. Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery. Int J Nanomedicine. 2006; 1(4):507-22.
    View PubMed
  241. Torbenson M. Emerging causes of morbidity and mortality in organ transplant patients. Current Opinion in Solid Organ Transplantation. 2006; 11(3):304-10.
  242. Hong K, Kobeiter H, Georgiades CS, Torbenson MS, Geschwind JF. Effects of the type of embolization particles on carboplatin concentration in liver tumors after transcatheter arterial chemoembolization in a rabbit model of liver cancer. J Vasc Interv Radiol. 2005 Dec; 16(12):1711-7.
    View PubMed
  243. Sicklick JK, Li YX, Choi SS, Qi Y, Chen W, Bustamante M, Huang J, Zdanowicz M, Camp T, Torbenson MS, Rojkind M, Diehl AM. Role for hedgehog signaling in hepatic stellate cell activation and viability. Lab Invest. 2005 Nov; 85(11):1368-80.
    View PubMed
  244. Klein WM, Molmenti EP, Colombani PM, Grover DS, Schwarz KB, Boitnott J, Torbenson MS. Primary liver carcinoma arising in people younger than 30 years. Am J Clin Pathol. 2005 Oct; 124(4):512-8.
    View PubMed
  245. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005 Jun; 41(6):1313-21.
    View PubMed
  246. Torbenson M, Grover D, Boitnott J, Klein A, Molmenti E. De novo hepatocellular carcinoma in a liver allograft associated with recurrent hepatitis B. Transplant Proc. 2005 Jun; 37(5):2205-6.
    View PubMed
  247. Kannangai R, Diehl AM, Sicklick J, Rojkind M, Thomas D, Torbenson M. Hepatic angiomyolipoma and hepatic stellate cells share a similar gene expression profile. Hum Pathol. 2005 Apr; 36(4):341-7.
    View PubMed
  248. Sulkowski MS, Mehta SH, Torbenson M, Afdhal NH, Mirel L, Moore RD, Thomas DL. Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. AIDS. 2005 Mar 24; 19(6):585-92.
    View PubMed
  249. Solga SF, Clark JM, Alkhuraishi AR, Torbenson M, Tabesh A, Schweitzer M, Diehl AM, Magnuson TH. Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients. Surg Obes Relat Dis. 2005 Jan-Feb; 1(1):6-11.
    View PubMed
  250. Kannangai R, Wang J, Liu QZ, Sahin F, Torbenson M. Survivin overexpression in hepatocellular carcinoma is associated with p53 dysregulation. Int J Gastrointest Cancer. 2005; 35(1):53-60.
    View PubMed
  251. Mehta SH, Thomas DL, Torbenson M, Brinkley S, Mirel L, Chaisson RE, Moore RD, Sulkowski MS. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection. Hepatology. 2005 Jan; 41(1):123-31.
    View PubMed
  252. Locke JE, Choti MA, Torbenson MS, Horton KM, Molmenti EP. Inflammatory pseudotumor of the liver. J Hepatobiliary Pancreat Surg. 2005; 12(4):314-6.
    View PubMed
  253. Sahin F, Kannangai R, Adegbola O, Wang J, Su G, Torbenson M. mTOR and P70 S6 kinase expression in primary liver neoplasms. Clin Cancer Res. 2004 Dec 15; 10(24):8421-5.
    View PubMed
  254. Ko YH, Smith BL, Wang Y, Pomper MG, Rini DA, Torbenson MS, Hullihen J, Pedersen PL. Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem Biophys Res Commun. 2004 Nov 5; 324(1):269-75.
    View PubMed
  255. Solga S, Alkhuraishe AR, Clark JM, Torbenson M, Greenwald A, Diehl AM, Magnuson T. Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci. 2004 Oct; 49(10):1578-83.
    View PubMed
  256. Torbenson M, Kannangai R, Abraham S, Sahin F, Choti M, Wang JZ. Concurrent evaluation of p53, beta-catenin, and alpha-fetoprotein expression in human hepatocellular carcinoma. Am J Clin Pathol. 2004 Sep; 122(3):377-82.
    View PubMed
  257. Kulesza P, Torbenson M, Sheth S, Erozan YS, Ali SZ. Cytopathologic grading of hepatocellular carcinoma on fine-needle aspiration. Cancer. 2004 Aug 25; 102(4):247-58.
    View PubMed
  258. Kannangai R, Molmenti E, Arrazola L, Klein A, Choti M, Thomas DL, Torbenson M. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection. J Viral Hepat. 2004 Jul; 11(4):297-301.
    View PubMed
  259. Kannangai R, Sahin F, Adegbola O, Ashfaq R, Su GH, Torbenson M. FHIT mRNA and protein expression in hepatocellular carcinoma. Mod Pathol. 2004 Jun; 17(6):653-9.
    View PubMed
  260. Oben JA, Roskams T, Yang S, Lin H, Sinelli N, Torbenson M, Smedh U, Moran TH, Li Z, Huang J, Thomas SA, Diehl AM. Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut. 2004 Mar; 53(3):438-45.
    View PubMed
  261. Lee J, Li S, Torbenson M, Liu QZ, Lind S, Mulvihill JJ, Bane B, Wang J. Leiomyosarcoma of the breast: a pathologic and comparative genomic hybridization study of two cases. Cancer Genet Cytogenet. 2004 Feb; 149(1):53-7.
    View PubMed
  262. Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology. 2004 Jan; 39(1):51-7.
    View PubMed
  263. Koteish A, Kannangai R, Abraham SC, Torbenson M. Colonic spirochetosis in children and adults. Am J Clin Pathol. 2003 Dec; 120(6):828-32.
    View PubMed
  264. Torbenson M, Wang JZ, Abraham S, Maitra A, Boitnott J. Bile ducts and ductules are positive for CD56 (N-CAM) in most cases of extrahepatic biliary atresia. Am J Surg Pathol. 2003 Nov; 27(11):1454-7.
    View PubMed
  265. Hoofring A, Boitnott J, Torbenson M. Three-dimensional reconstruction of hepatic bridging fibrosis in chronic hepatitis C viral infection. J Hepatol. 2003 Nov; 39(5):738-41.
    View PubMed
  266. Hawxby AM, Torbenson M, Fishman E, Lawler L, Arrazola LM, Klein AS. Juxta-caval hepatic angiomyolipoma masquerading as hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2003 Nov; 2(4):617-21.
    View PubMed
  267. Ulanet DB, Torbenson M, Dang CV, Casciola-Rosen L, Rosen A. Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response. Proc Natl Acad Sci U S A. 2003 Oct 14; 100(21):12361-6. Epub 2003 Sep 30.
    View PubMed
  268. Kamel IR, Bluemke DA, Ramsey D, Abusedera M, Torbenson M, Eng J, Szarf G, Geschwind JF. Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol. 2003 Sep; 181(3):708-10.
    View PubMed
  269. Oben JA, Roskams T, Yang S, Lin H, Sinelli N, Li Z, Torbenson M, Huang J, Guarino P, Kafrouni M, Diehl AM. Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury. Hepatology. 2003 Sep; 38(3):664-73.
    View PubMed
  270. Wang J, Blakey GL, Zhang L, Bane B, Torbenson M, Li S. Uterine tumor resembling ovarian sex cord tumor: report of a case with t(X;6)(p22.3;q23.1) and t(4;18)(q21.1;q21.3). Diagn Mol Pathol. 2003 Sep; 12(3):174-80.
    View PubMed
  271. Oben JA, Roskams T, Yang S, Lin H, Sinelli N, Li Z, Torbenson M, Thomas SA, Diehl AM. Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice. Biochem Biophys Res Commun. 2003 Aug 22; 308(2):284-92.
    View PubMed
  272. Dang DT, Chen X, Feng J, Torbenson M, Dang LH, Yang VW. Overexpression of Kruppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity. Oncogene. 2003 May 29; 22(22):3424-30.
    View PubMed
  273. Wang J, Torbenson M, Wang Q, Ro JY, Becich M. Expression of inducible nitric oxide synthase in paired neoplastic and non-neoplastic primary prostate cell cultures and prostatectomy specimen. Urol Oncol. 2003 Mar-Apr; 21(2):117-22.
    View PubMed
  274. Akpek G, Chinratanalab W, Lee LA, Torbenson M, Hallick JP, Anders V, Vogelsang GB. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study. Biol Blood Marrow Transplant. 2003 Jan; 9(1):46-51.
    View PubMed
  275. Torbenson M, Erlen J. A case study of the Lash's Bitters company - Advertising changes after the Federal Food and Drugs Act of 1906 and the Sherley Amendment of 1912. Pharm Hist. 2003; 45(4):139-49.
    View PubMed
  276. Akpek G, Boitnott JK, Lee LA, Hallick JP, Torbenson M, Jacobsohn DA, Arai S, Anders V, Vogelsang GB. Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion. Blood. 2002 Dec 1; 100(12):3903-7. Epub 2002 Jul 18.
    View PubMed
  277. Gebo KA, Herlong HF, Torbenson MS, Jenckes MW, Chander G, Ghanem KG, El-Kamary SS, Sulkowski M, Bass EB. Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology. 2002 Nov; 36(5 Suppl 1):S161-72.
    View PubMed
  278. Chander G, Sulkowski MS, Jenckes MW, Torbenson MS, Herlong HF, Bass EB, Gebo KA. Treatment of chronic hepatitis C: a systematic review. Hepatology. 2002 Nov; 36(5 Suppl 1):S135-44.
    View PubMed
  279. Gebo KA, Chander G, Jenckes MW, Ghanem KG, Herlong HF, Torbenson MS, El-Kamary SS, Bass EB. Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review. Hepatology. 2002 Nov; 36(5 Suppl 1):S84-92.
    View PubMed
  280. Montgomery E, Torbenson MS, Kaushal M, Fisher C, Abraham SC. Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol. 2002 Oct; 26(10):1296-301.
    View PubMed
  281. Cruz-Correa M, Milligan F, Giardiello FM, Bayless TM, Torbenson M, Yardley JH, Jackson FW, Wilson Jackson F. Collagenous colitis with mucosal tears on endoscopic insufflation: a unique presentation. Gut. 2002 Oct; 51(4):600.
    View PubMed
  282. Torbenson M, Marinopoulos S, Dang DT, Choti M, Ashfaq R, Maitra A, Boitnott J, Wilentz RE. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling. Hum Pathol. 2002 Sep; 33(9):871-6.
    View PubMed
  283. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002 Aug; 2(8):479-86.
    View PubMed
  284. Torbenson M, Wang J, Choti M, Ashfaq R, Maitra A, Wilentz RE, Boitnott J. Hepatocellular carcinomas show abnormal expression of fibronectin protein. Mod Pathol. 2002 Aug; 15(8):826-30.
    View PubMed
  285. Geschwind JF, Ko YH, Torbenson MS, Magee C, Pedersen PL. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res. 2002 Jul 15; 62(14):3909-13.
    View PubMed
  286. Torbenson M, Lee JH, Cruz-Correa M, Ravich W, Rastgar K, Abraham SC, Wu TT. Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis. Mod Pathol. 2002 Jul; 15(7):718-23.
    View PubMed
  287. Torbenson M, Yang SQ, Liu HZ, Huang J, Gage W, Diehl AM. STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers. Am J Pathol. 2002 Jul; 161(1):155-61.
    View PubMed
  288. Gebo KA, Jenckes MW, Chander G, Torbenson MS, Ghanem KG, Herlong HF, Sulkowski MS, El-Kamary SS, Harris KA, Guedelhoefer OC, Bass EB. Management of chronic hepatitis C. Evid Rep Technol Assess (Summ). 2002 Jun(60):1-7.
    View PubMed
  289. Torbenson M, Montgomery EA, Iacobuzio-Donahue C, Yardley JH, Wu TT, Abraham SC. Colchicine effect in a colonic hyperplastic polyp. A lesion mimicking serrated adenoma. Arch Pathol Lab Med. 2002 May; 126(5):615-7.
    View PubMed
  290. Rai R, Wilson LE, Astemborski J, Anania F, Torbenson M, Spoler C, Vlahov D, Strathdee SA, Boitnott J, Nelson KE, Thomas DL. Severity and correlates of liver disease in hepatitis C virus-infected injection drug users. Hepatology. 2002 May; 35(5):1247-55.
    View PubMed
  291. Torbenson M, Lee JH, Choti M, Gage W, Abraham SC, Montgomery E, Boitnott J, Wu TT. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway. Mod Pathol. 2002 Mar; 15(3):189-96.
    View PubMed
  292. Torbenson M, Abraham SC, Boitnott J, Yardley JH, Wu TT. Autoimmune gastritis: distinct histological and immunohistochemical findings before complete loss of oxyntic glands. Mod Pathol. 2002 Feb; 15(2):102-9.
    View PubMed
  293. Torbenson M, Randhawa P. Arcuate and interlobular phlebitis in renal allografts. Hum Pathol. 2001 Dec; 32(12):1388-91.
    View PubMed
  294. Bellamy CO, DiMartini AM, Ruppert K, Jain A, Dodson F, Torbenson M, Starzl TE, Fung JJ, Demetris AJ. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation. 2001 Aug 27; 72(4):619-26.
    View PubMed
  295. Torbenson MS, Wang J, Nichols L, Jain AB, Fung JJ, Nalesnik MA. Occult nonhematopoietic malignancies present at autopsy in solid organ transplant patients who died within 100 days. Transplantation. 2001 Jan 15; 71(1):64-9.
    View PubMed
  296. Torbenson B, Erlen J, Torbenson M. Pharmacy in History. Pharmacy in History. 2001; 43:14-22.
  297. Wang J, Krill D, Torbenson M, Wang Q, Bisceglia M, Stoner J, Thomas A, DeFlavia P, Dhir R, Becich MJ. Expression of cadherins and catenins in paired tumor and non-neoplastic primary prostate cultures and corresponding prostatectomy specimens. Urol Res. 2000 Oct; 28(5):308-15.
    View PubMed
  298. Minervini MI, Torbenson M, Scantlebury V, Vivas C, Jordan M, Shapiro R, Randhawa PS. Acute renal allograft rejection with severe tubulitis (Banff 1997 grade IB). Am J Surg Pathol. 2000 Apr; 24(4):553-8.
    View PubMed
  299. Torbenson M, Wang J, Nichols L, Randhawa P, Nalesnik MA. Renal cortical neoplasms in long term survivors of solid organ transplantation. Transplantation. 2000 Mar 15; 69(5):864-8.
    View PubMed
  300. Torbenson M. Lash's - a bitter medicine: biochemical analysis of an historical proprietary medicine. Hist Archaeol. 2000; 34(2):56-64.
    View PubMed
  301. Torbenson M, Dhir R, Nangia A, Becich MJ, Kapadia SB. Prostatic carcinoma with signet ring cells: a clinicopathologic and immunohistochemical analysis of 12 cases, with review of the literature. Mod Pathol. 1998 Jun; 11(6):552-9.
    View PubMed
  302. Torbenson M, Wang J, Nichols L, Jain A, Fung J, Nalesnik MA. Causes of death in autopsied liver transplantation patients. Mod Pathol. 1998 Jan; 11(1):37-46.
    View PubMed
  303. Torbenson M, Langsjoen O, Aufderheide A. Human remains from Mckinstry mound two. Plains Anthropologist. 1996; 41(155):71-92.
  304. Torbenson M, Langsjoen O, Aufderheide A. Laurel culture human remains from Smith mounds three and four. Plains Anthrologist. 1994; 39(150):429-44.
  305. Torbenson M, Aufderheide A, Johnson E. Punctured human long bones from Smith mound four, Minnesota. American Antiquity. 1992; 57(3):506-14.